Analyst recommendations: Amgen, Apple, AstraZeneca, FedEx, T-Mobile US...

09/23/2021 | 06:29am

Every day, find a selection of analysts' recommendations covering the main markets of North America and the U.K. The list includes only companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.

 

  • Amgen: Daiwa Securities downgrades to neutral from outperform. PT up 3% to $220
  • Apple: Tigress Financial raises Apple PT to $198 from $182, maintains Strong Buy rating
  • AstraZeneca: Credit Suisse retains its positive opinion on the stock with a Buy rating. The target price remains unchanged at GBp 9000.
  • AvalonBay: Goldman Sachs reinstated coverage with a recommendation of buy. PT raised 15% to $257
  • Brookfield Renewable Partners: Raymond James upgrades to Outperform from Market Perform, adjusts PT to $44 from $41
  • Camden Property: Goldman Sachs reinstated coverage with a recommendation of buy. PT up 14% to $172
  • Discovery : UBS adjusts price target on discovery to $27 from $38, maintains neutral rating
  • Equity Residential: Goldman Sachs reinstated coverage with a recommendation of neutral. PT up 5.7% to $86
  • FedEx : UBS adjusts price target on fedex to $369 from $380, maintains buy rating
  • InnovAge : Goldman Sachs adjusts PT to $17 From $28, maintains Buy rating
  • Mid-America: Goldman Sachs reinstated coverage with a recommendation of neutral. PT up 6.2% to $202
  • Pentair: Oppenheimer adjusts PT to $84 From $80, maintains Outperform rating
  • Raymond James Financial : Morgan Stanley adjusts Price Target to $66.67 from $100, maintains Overweight rating
  • Rolls-Royce: Berenberg has maintained his recommendation on the stock with a Buy rating. The target price is reviewed upwards from GBp 150 to GBp 160.
  • T-Mobile U.S.: Goldman Sachs retains its positive opinion on the stock with a Buy rating. The target price remains unchanged at USD 160.
  • Trimble: Morgan Stanley downgrades to underweight from equal-weight. PT down 18% to $74
  • UDR: Goldman Sachs reinstated coverage with a recommendation of buy. PT raised 12% to $60
  • Vodafone: Goldman Sachs keeps its Buy rating on the stock. The target price is still set at GBp 180.
© MarketScreener.com 2021
Copier lien
Latest news about "Companies"
21h ago
21h ago
21h ago
21h ago
22h ago